4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001209191-21-069418
Chief Scientific Officer acquired 36,524 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Beskrovnaya Oxana Chief Scientific Officer | 2021-12-10 | Grant or award | +36,524 | 54,369 | D | ||
| Derivatives | |||||||
| Beskrovnaya Oxana Chief Scientific Officer | 2021-12-10 | Grant or award · Stock Option (right to buy) | +54,786 | 54,786 | D | ||
Loading xslF345X03/doc4.xml…